Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular
Graham M West1, Francis S Willard2, Kyle W Sloop3
1Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America; Mass Spectrometry and Proteomics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.
Abstract:
Activation of the glucagon-like peptide-1 receptor (GLP-1R) in pancreatic β-cells potentiates insulin production and is a current therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). Like other class B G protein-coupled receptors (GPCRs), the GLP-1R contains an N-terminal extracellular ligand binding domain. N-terminal truncations on the peptide agonist generate antagonists capable of binding to the extracellular domain, but not capable of activating full length receptor. The main objective of this study was to use Hydrogen/deuterium exchange (HDX) to identify how the amide hydrogen bonding network of peptide ligands and the extracellular domain of GLP-1R (nGLP-1R) were altered by binding interactions and to then use this platform to validate direct binding events for putative GLP-1R small molecule ligands. The HDX studies presented here for two glucagon-like peptide-1 receptor (GLP-1R) peptide ligands indicates that the antagonist exendin-4[9-39] is significantly destabilized in the presence of nonionic detergents as compared to the agonist exendin-4. Furthermore, HDX can detect stabilization of exendin-4 and exendin-4[9-39] hydrogen bonding networks at the N-terminal helix [Val19 to Lys27] upon binding to the N-terminal extracellular domain of GLP-1R (nGLP-1R). In addition we show hydrogen bonding network stabilization on nGLP-1R in response to ligand binding, and validate direct binding events with the extracellular domain of the receptor for putative GLP-1R small molecule ligands.
Insights
Hydrogen/deuterium exchange (HDX) reveals how peptide ligands interact with the glucagon-like peptide-1 receptor (GLP-1R) extracellular domain. This method validates binding for small molecule ligands, aiding type 2 diabetes mellitus (T2DM) drug development.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- The glucagon-like peptide-1 receptor (GLP-1R) is a key therapeutic target for type 2 diabetes mellitus (T2DM).
- GLP-1R, a class B G protein-coupled receptor (GPCR), has an N-terminal extracellular ligand-binding domain.
- Modified peptide agonists can act as antagonists by binding without full receptor activation.
Purpose of the Study:
- To investigate alterations in hydrogen bonding networks of GLP-1R peptide ligands and its N-terminal extracellular domain (nGLP-1R) upon ligand binding using Hydrogen/deuterium exchange (HDX).
- To establish HDX as a platform for validating direct binding of small molecule ligands to nGLP-1R.
Main Methods:
- Hydrogen/deuterium exchange (HDX) mass spectrometry.
- Analysis of peptide ligand (exendin-4 and exendin-4[9-39]) and nGLP-1R interactions.
- Assessment of ligand stability in the presence of nonionic detergents.
Main Results:
- HDX detected differential stabilization of hydrogen bonding networks for agonist exendin-4 versus antagonist exendin-4[9-39].
- Ligand binding stabilized hydrogen bonding networks in the N-terminal helix of both exendin-4 and exendin-4[9-39].
- HDX confirmed ligand-induced stabilization within the nGLP-1R structure and validated direct binding of small molecule ligands.
Conclusions:
- HDX is effective in characterizing ligand-receptor interactions at the molecular level for GLP-1R.
- The study validates HDX as a method for confirming direct binding of small molecule ligands to the GLP-1R extracellular domain.
- Findings contribute to understanding GLP-1R pharmacology and developing novel T2DM therapeutics.
More Related Videos
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
05:51Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells
Published on: June 15, 2013
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GPCRs Regulate Adenylyl Cylase Activity
Insulin: The Receptor and Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Ligand Binding and Linkage